- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02563808
Impact of Anticipated Regret Incorporation Into Patient Decision Aids
April 18, 2023 updated by: University of Pennsylvania
Impact of Anticipated Regret on Decision-Making in Preference Sensitive Care for Breast and Prostate Cancer
The purpose of this study is to investigate the impact of incorporating "anticipated regret " into standard patient decision aids.
Participants in the Wharton Behavioral Lab will be administered a standard patient decision aid and an "anticipated regret" augmented decision aid.
Participants will complete a computerized survey about their experiences with each version, and their answers will be assessed for potential differences associated with the incorporation of "Anticipated Regret."
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited through the Wharton Behavioral Lab.
Upon arrival males will be provided with two decision aids focusing on prostate cancer, while females will be provided with two decision aids focusing on early breast cancer.
One of these decision aids will be a standard version, and one of these will be the anticipated regret-augmented version.
Participants will be randomized to which version they receive first to minimize the effect of presentation order.
After reviewing the materials, participants will immediately complete a computerized survey at their work stations that will ask them to answer questions based on the materials presented as well as how any hypothetical treatment decisions they would be asked to make would have been influenced by them.
Because these are healthy subjects participating in a hypothetical decision-making process for sole purpose of research, the intervention can neither be categorized as experimental or as the standard of care.
Study Type
Interventional
Enrollment (Actual)
189
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy females ages 18 years or older
Exclusion Criteria:
- Under age 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Decision Aid
The brochure with standard information on surgery for early-stage breast cancer
|
Females will receive standard decisions aid for early stage breast cancer.
|
Experimental: Post-surgical Regret Decision Aid
The brochure that incorporates additional information on the rates of regret after surgical treatment of early-stage breast cancer.
|
Females will receive anticipated regret-augmented version for early breast cancer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in Consideration of Regret
Time Frame: 11 months
|
Compare decisions about a hypothetical surgery for breast cancer, and examined whether regret is a consideration in treatment decisions between those who received the experimental and those who received the standard version of the decision aid.
The values represent numbers of participants who reported that regret played a role in their decision-making.
|
11 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lee Fleisher, MD, UPenn, Chairman, Anesthesiology & Critical Care
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
September 28, 2015
First Submitted That Met QC Criteria
September 29, 2015
First Posted (Estimate)
September 30, 2015
Study Record Updates
Last Update Posted (Actual)
April 20, 2023
Last Update Submitted That Met QC Criteria
April 18, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 817436
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Regret
-
University Hospital, GenevaCompletedStress, Psychological | Sleep | Regret | Nightshift Work | Handoff SessionsSwitzerland
Clinical Trials on Standard Decision Aid
-
Christiana Care Health ServicesUniversity of Michigan; NorthShore University HealthSystem; Virtua HealthCompleted
-
Yale UniversityCompletedHIV Infections | Substance AbuseUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingChronic Kidney Diseases | CKDUnited States
-
Mario Negri Institute for Pharmacological ResearchCompleted
-
Medical College of WisconsinThe Cleveland ClinicNot yet recruitingIschemia | Coronary Artery Disease | Heart Failure | Hypertension | Diabetes Mellitus | Cardiomyopathies | Peripheral Artery Disease | CardiotoxicityUnited States
-
University of Wisconsin, MadisonCompletedBreast Cancer | Knowledge, Attitudes, Practice
-
Massachusetts General HospitalCompletedCoronary Artery Disease | Stable AnginaUnited States
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Institut de Recerca Biomèdica de LleidaInstitut Català d'Oncologia; Hospital del Mar; Canary Islands Health ServiceCompletedBreast Cancer ScreeningSpain